VADUZ, Liechtenstein, 11 May 2022 – bonyf will be exhibiting, together with it’s UK distributor, WHW Plastics Ltd, at the British Dental Conference & Dentistry Show in Birmingham ...
Author: bonyf
Post
Bleeding while brushing teeth is a sign of gum disease, a condition linked to the development of Alzheimer’s disease
Ghent (Belgium), 10 May 2022, 08.00am; bonyf NV (Mnemonic: MLBON), the next generation oral comfort expert, supports International Gum Health Day 2022 and ...
Post
Are vaseline-based denture creams a cause for health concern? bonyf offers an alternative solution to this latest controversy
Ghent (Belgium), 6 April 2022, 06.00pm; bonyf NV (ticker: MLBON), experts in next-generation oral and dental care and the producer of OlivaFix® Gold, the first and ...
Post
Boursier.com: Interview With Bart De Wever, Bonyf Scientific Director. Bonyf discreetly listed on the Paris Stock Exchange, Euronext Access, the Free Aftermarket, without raising money. What is the business of the company?
Bd W .: Bonyf’s mission is to improve the lives and comfort of people suffering from oral diseases through innovative oral products. The long phase of R&D has resulted
Post
bonyf raises awareness on World Oral Health Day
Ghent (Belgium), 20 March 2022, 08.00am; bonyf NV (ticker: MLBON), experts in next generation oral and dental care, joins World Oral Health Day on 20 March 2022 in emphasising the importance of oral care, your mouth being a vital organ for the prevention of many diseases.
Post
First day of listing and start of trading on Euronext Access
Ghent (Belgium), 17 March 2022, 08:45 am; bonyf NV (Ticker symbol: MLBON), the experts in next-generation oral and dental care, announces its listing today on the Euronext Access Paris Stock
Post
bonyf announces listing on Paris Euronext
Ghent (Belgium), 15 March 2022, 10:15am; bonyf NV (Ticker symbol: MLBON), the experts in next-generation oral and dental care, announces it will go public on Euronext Access® by direct listing on 17 March 2022.
Post
New preliminary studies are further proving PerioTabs® efficacy
VADUZ, Liechtenstein, 1 March 2022 – Researchers at the University of Zurich, Switzerland, have evaluated the prophylactic and therapeutic efficacy...
Post
Further new clinical evidence that bonyf’s PerioTabs® reduces bleeding gums and plaque accumulation
VADUZ, Liechtenstein, 16 December, 2021 – PerioTabs®, a home-care gum and teeth brushing solution based on bonyf’s non-antibiotic biofilm removal...
Post
bonyf’s latest innovation, PerioTabs®, performs better than chlorhexidine in treating dental implant related infections
VADUZ, Liechtenstein, 29 October 2021 – A recently published clinical trial involving 40 patients suffering from dental implant related infections...